Early-Stop trial tests antibody cocktail for mild COVID cases
NCT ID NCT05081388
Summary
This study tested a new antibody combination treatment (REGN14256+imdevimab) for adults with mild COVID-19 who were otherwise healthy. The goal was to see if the treatment was safe and could help clear the virus faster and reduce symptoms. The trial was terminated early and only enrolled 25 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AGA Clinical Trials
Hialeah, Florida, 33012, United States
-
Advanced Diagnostics Clinic, River Oaks Hospital and Clinics
Houston, Texas, 77027, United States
-
Ark Clinical Research
Long Beach, California, 90806, United States
-
Bio-Medical Research LLC
Miami, Florida, 33184, United States
-
Carolina Medical Research
Clinton, South Carolina, 29325, United States
-
Charisma Research and Medical Center
Miami Lakes, Florida, 33014, United States
-
Chicago Clinical Research Institute
Chicago, Illinois, 60607, United States
-
Forte Family Practice
Las Vegas, Nevada, 89103, United States
-
Global Medical Trials
Miami, Florida, 33174, United States
-
IACT Health
Columbus, Georgia, 31904, United States
-
NYC H+H / Jacobi Medical Center
The Bronx, New York, 10461, United States
-
New York Health and Hospitals / Lincoln
The Bronx, New York, 10451, United States
-
Olive Branch Family Medical Center
Olive Branch, Mississippi, 38654, United States
-
PNS Clinical Research, LLC
Mission Viejo, California, 92691, United States
-
PharmaTex Research, LLC
Amarillo, Texas, 79109, United States
-
Project 4 Research, Inc.
Miami, Florida, 33125, United States
-
Regeneron Research Site
La Mesa, California, 91941, United States
-
Regeneron Research Site
Ft. Pierce, Florida, 34982, United States
-
Regeneron Research Site
Loxahatchee Groves, Florida, 33470, United States
-
Regeneron Research Site
Winter Park, Florida, 32789, United States
-
Regeneron Research Site
Ames, Iowa, 50010, United States
-
Regeneron Research Site
Marrero, Louisiana, 70072, United States
-
Regeneron Research Site
Wilmington, North Carolina, 28401, United States
-
Regeneron Research Site
Dayton, Ohio, 45409, United States
-
Regeneron Research Site
Houston, Texas, 77030, United States
-
Regeneron Research Site
Houston, Texas, 77093, United States
-
Triple O Research Institute, P.A.
West Palm Beach, Florida, 33407, United States
-
Universal Medical and Research Center, LLC
Miami, Florida, 33126, United States
Conditions
Explore the condition pages connected to this study.